Related Articles by Review for PMID: 30571051

Year	Number of Results
2000	1
2003	1
2006	1
2007	2
2008	1
2009	1
2010	1
2011	1
2012	2
2014	2
2015	1
2016	4
2017	4
2018	2
2019	6
2020	5
2021	4
2022	4
2023	3
2025	1

1

Taylor BN, Mueller M, Sauls RS. Taylor BN, et al. 2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30571051 Free Books & Documents.

2

A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics.

Badowski ME. Badowski ME. Cancer Chemother Pharmacol. 2017 Sep;80(3):441-449. doi: 10.1007/s00280-017-3387-5. Epub 2017 Aug 5. Cancer Chemother Pharmacol. 2017. PMID: 28780725 Free PMC article. Review.

3

Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.

Alderman B, Hui D, Mukhopadhyay S, Bouleuc C, Case AA, Amano K, Crawford GB, de Feo G, Sbrana A, Tanco K, To J, Garsed J, Davis M. Alderman B, et al. Support Care Cancer. 2022 Dec 16;31(1):39. doi: 10.1007/s00520-022-07480-x. Support Care Cancer. 2022. PMID: 36525085 Review.

4

Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.

Todaro B. Todaro B. J Natl Compr Canc Netw. 2012 Apr;10(4):487-92. doi: 10.6004/jnccn.2012.0048. J Natl Compr Canc Netw. 2012. PMID: 22491047 Review.

5

Cannabinoids: Therapeutic Use in Clinical Practice.

Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Pagano C, et al. Int J Mol Sci. 2022 Mar 19;23(6):3344. doi: 10.3390/ijms23063344. Int J Mol Sci. 2022. PMID: 35328765 Free PMC article. Review.

6

Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.

Pergolizzi JV Jr, Taylor R, LeQuang JA, Zampogna G, Raffa RB. Pergolizzi JV Jr, et al. Cancer Chemother Pharmacol. 2017 Mar;79(3):467-477. doi: 10.1007/s00280-017-3257-1. Epub 2017 Feb 24. Cancer Chemother Pharmacol. 2017. PMID: 28235999 Review.

7

Cannabinoids in treatment-resistant epilepsy: A review.

O'Connell BK, Gloss D, Devinsky O. O'Connell BK, et al. Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8. Epilepsy Behav. 2017. PMID: 28188044 Review.

8

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics.

May MB, Glode AE. May MB, et al. Cancer Manag Res. 2016 May 12;8:49-55. doi: 10.2147/CMAR.S81425. eCollection 2016. Cancer Manag Res. 2016. PMID: 27274310 Free PMC article. Review.

9

Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.

Shah SA, Gupta AS, Kumar P. Shah SA, et al. J Cancer Res Ther. 2021 Jan-Mar;17(1):1-9. doi: 10.4103/jcrt.JCRT_488_18. J Cancer Res Ther. 2021. PMID: 33723124 Free article. Review.

10

The use of cannabis in supportive care and treatment of brain tumor.

Likar R, Nahler G. Likar R, et al. Neurooncol Pract. 2017 Sep;4(3):151-160. doi: 10.1093/nop/npw027. Epub 2017 Jan 18. Neurooncol Pract. 2017. PMID: 31385997 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 30571051

42 results

Results by year